| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1G1 OR4D6 OR2B3 OR4D11 GPRC5D TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 3.52e-15 | 884 | 28 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1G1 OR4D6 OR2B3 OR4D11 GPRC5D TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 2.53e-12 | 1353 | 28 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 1.83e-10 | 431 | 28 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.06e-06 | 133 | 28 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.36e-06 | 140 | 28 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | tachykinin receptor activity | 5.68e-06 | 3 | 28 | 2 | GO:0004995 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.23e-03 | 37 | 28 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.50e-03 | 53 | 28 | 2 | GO:0008188 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1G1 OR4D6 OR2B3 OR4D11 GPRC5D TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 2.47e-12 | 1395 | 28 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 1.37e-10 | 432 | 28 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 2.81e-10 | 465 | 28 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 4.23e-10 | 485 | 28 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 8.95e-10 | 524 | 28 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 1.12e-09 | 722 | 28 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 1.35e-09 | 547 | 28 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 2.46e-09 | 582 | 28 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception | OR1G1 OR4D6 OR2B3 OR4D11 CHD7 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 6.74e-08 | 1072 | 28 | 11 | GO:0007600 |
| GeneOntologyBiologicalProcess | tachykinin receptor signaling pathway | 4.95e-05 | 8 | 28 | 2 | GO:0007217 | |
| GeneOntologyBiologicalProcess | positive regulation of uterine smooth muscle contraction | 6.36e-05 | 9 | 28 | 2 | GO:0070474 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 1.16e-04 | 12 | 28 | 2 | GO:0070472 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 1.37e-04 | 13 | 28 | 2 | GO:0070471 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium-dependent cell motility | 2.68e-04 | 18 | 28 | 2 | GO:2000155 | |
| GeneOntologyBiologicalProcess | positive regulation of flagellated sperm motility | 2.68e-04 | 18 | 28 | 2 | GO:1902093 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium movement | 3.00e-04 | 19 | 28 | 2 | GO:0003353 | |
| GeneOntologyBiologicalProcess | regulation of flagellated sperm motility | 6.57e-04 | 28 | 28 | 2 | GO:1901317 | |
| HumanPheno | Abnormal circulating androgen level | 1.27e-07 | 98 | 8 | 5 | HP:0030347 | |
| HumanPheno | Abnormal circulating sex hormone concentration | 3.25e-07 | 118 | 8 | 5 | HP:0033799 | |
| HumanPheno | Abnormal circulating testosterone concentration | 4.58e-06 | 84 | 8 | 4 | HP:0030087 | |
| HumanPheno | Hypoplasia of the ovary | 6.89e-06 | 93 | 8 | 4 | HP:0008724 | |
| HumanPheno | Aplasia/Hypoplasia of the ovary | 7.51e-06 | 95 | 8 | 4 | HP:0010462 | |
| HumanPheno | Abnormality of the uterus | 1.52e-05 | 256 | 8 | 5 | HP:0000130 | |
| HumanPheno | Abnormal circulating hormone concentration | 2.51e-05 | 855 | 8 | 7 | HP:0003117 | |
| HumanPheno | Primary amenorrhea | 2.62e-05 | 130 | 8 | 4 | HP:0000786 | |
| HumanPheno | Absence of secondary sex characteristics | 3.27e-05 | 44 | 8 | 3 | HP:0008187 | |
| HumanPheno | Abnormal ovarian morphology | 9.24e-05 | 179 | 8 | 4 | HP:0031065 | |
| HumanPheno | Abnormal morphology of female internal genitalia | 1.07e-04 | 665 | 8 | 6 | HP:0000008 | |
| HumanPheno | Decreased serum testosterone concentration | 1.16e-04 | 67 | 8 | 3 | HP:0040171 | |
| HumanPheno | Secondary amenorrhea | 1.32e-04 | 70 | 8 | 3 | HP:0000869 | |
| HumanPheno | Decreased circulating androgen concentration | 1.32e-04 | 70 | 8 | 3 | HP:0030349 | |
| HumanPheno | Aplasia/Hypoplasia of the breasts | 1.44e-04 | 72 | 8 | 3 | HP:0010311 | |
| HumanPheno | Amenorrhea | 1.48e-04 | 202 | 8 | 4 | HP:0000141 | |
| HumanPheno | Hypolipidemia | 1.76e-04 | 77 | 8 | 3 | HP:0045014 | |
| HumanPheno | Delayed puberty | 1.79e-04 | 212 | 8 | 4 | HP:0000823 | |
| HumanPheno | Abnormality of the female genitalia | 2.00e-04 | 741 | 8 | 6 | HP:0010460 | |
| HumanPheno | Aplasia/hypoplasia of the uterus | 2.05e-04 | 81 | 8 | 3 | HP:0008684 | |
| HumanPheno | Abnormal breast morphology | 2.14e-04 | 441 | 8 | 5 | HP:0031093 | |
| HumanPheno | Abnormality of the breast | 2.28e-04 | 447 | 8 | 5 | HP:0000769 | |
| HumanPheno | Abnormal circulating lipid concentration | 2.43e-04 | 453 | 8 | 5 | HP:0003119 | |
| HumanPheno | Abnormal ovarian physiology | 2.99e-04 | 92 | 8 | 3 | HP:0031066 | |
| HumanPheno | Increased female libido | 3.26e-04 | 18 | 8 | 2 | HP:0030019 | |
| HumanPheno | Increased circulating androgen concentration | 3.26e-04 | 18 | 8 | 2 | HP:0030348 | |
| HumanPheno | Increased libido | 3.26e-04 | 18 | 8 | 2 | HP:0046503 | |
| HumanPheno | Hypertelorism | 3.83e-04 | 830 | 8 | 6 | HP:0000316 | |
| HumanPheno | Gynecomastia | 4.30e-04 | 104 | 8 | 3 | HP:0000771 | |
| HumanPheno | Male breast abnormality | 4.30e-04 | 104 | 8 | 3 | HP:0000770 | |
| HumanPheno | Hypothalamic gonadotropin-releasing hormone deficiency | 4.47e-04 | 21 | 8 | 2 | HP:0003164 | |
| HumanPheno | Abnormal gonadotropin-releasing hormone concentration | 4.47e-04 | 21 | 8 | 2 | HP:0500012 | |
| HumanPheno | Eunuchoid habitus | 4.91e-04 | 22 | 8 | 2 | HP:0003782 | |
| HumanPheno | Micropenis | 5.10e-04 | 278 | 8 | 4 | HP:0000054 | |
| HumanPheno | Abnormality of the ovary | 5.10e-04 | 278 | 8 | 4 | HP:0000137 | |
| HumanPheno | Wide intermamillary distance | 7.21e-04 | 124 | 8 | 3 | HP:0006610 | |
| HumanPheno | Abnormal intermamillary distance | 7.21e-04 | 124 | 8 | 3 | HP:0040157 | |
| HumanPheno | Abnormal hair morphology | 7.99e-04 | 1424 | 8 | 7 | HP:0001595 | |
| HumanPheno | Female hypogonadism | 7.99e-04 | 28 | 8 | 2 | HP:0000134 | |
| HumanPheno | Growth hormone and pituitary abnormality | 8.64e-04 | 319 | 8 | 4 | HP:0000844 | |
| HumanPheno | Abnormality of the pituitary gland | 8.64e-04 | 319 | 8 | 4 | HP:0000838 | |
| HumanPheno | Osteoporosis | 9.16e-04 | 324 | 8 | 4 | HP:0000939 | |
| HumanPheno | Irregular menstruation | 9.71e-04 | 329 | 8 | 4 | HP:0000858 | |
| HumanPheno | Abnormality of the menstrual cycle | 9.71e-04 | 329 | 8 | 4 | HP:0000140 | |
| HumanPheno | Absence of pubertal development | 9.81e-04 | 31 | 8 | 2 | HP:0008197 | |
| HumanPheno | Bimanual synkinesia | 1.05e-03 | 32 | 8 | 2 | HP:0001335 | |
| HumanPheno | Synkinesis | 1.05e-03 | 32 | 8 | 2 | HP:0034980 | |
| HumanPheno | Anal atresia | 1.09e-03 | 143 | 8 | 3 | HP:0002023 | |
| HumanPheno | Aplasia/Hypoplasia of the tibia | 1.11e-03 | 33 | 8 | 2 | HP:0005772 | |
| HumanPheno | Renal hypoplasia | 1.19e-03 | 147 | 8 | 3 | HP:0000089 | |
| HumanPheno | Arrhinencephaly | 1.25e-03 | 35 | 8 | 2 | HP:0002139 | |
| HumanPheno | Delayed skeletal maturation | 1.26e-03 | 352 | 8 | 4 | HP:0002750 | |
| HumanPheno | Renal hypoplasia/aplasia | 1.35e-03 | 359 | 8 | 4 | HP:0008678 | |
| HumanPheno | Dyspareunia | 1.40e-03 | 37 | 8 | 2 | HP:0030016 | |
| HumanPheno | Abnormality of the anterior pituitary | 1.45e-03 | 366 | 8 | 4 | HP:0011747 | |
| HumanPheno | Gonadal dysgenesis | 1.48e-03 | 38 | 8 | 2 | HP:0000133 | |
| HumanPheno | Streak ovary | 1.55e-03 | 39 | 8 | 2 | HP:0010464 | |
| HumanPheno | Decreased fertility | 1.68e-03 | 380 | 8 | 4 | HP:0000144 | |
| HumanPheno | Sparse hair | 1.73e-03 | 383 | 8 | 4 | HP:0008070 | |
| HumanPheno | Abnormal libido | 1.80e-03 | 42 | 8 | 2 | HP:0031845 | |
| HumanPheno | Abnormal pituitary gland morphology | 1.83e-03 | 389 | 8 | 4 | HP:0012503 | |
| HumanPheno | Aplasia/Hypoplasia of the thymus | 1.89e-03 | 43 | 8 | 2 | HP:0010515 | |
| HumanPheno | Abnormal female reproductive system physiology | 1.96e-03 | 396 | 8 | 4 | HP:0030012 | |
| HumanPheno | Abnormality of hair density | 1.99e-03 | 398 | 8 | 4 | HP:0011357 | |
| HumanPheno | Abnormal penis morphology | 2.04e-03 | 712 | 8 | 5 | HP:0000036 | |
| HumanPheno | Male hypogonadism | 2.07e-03 | 45 | 8 | 2 | HP:0000026 | |
| HumanPheno | Abnormality of globe location | 2.09e-03 | 1122 | 8 | 6 | HP:0100886 | |
| HumanPheno | Abnormality of skeletal maturation | 2.13e-03 | 405 | 8 | 4 | HP:0000927 | |
| HumanPheno | Breast hypoplasia | 2.16e-03 | 46 | 8 | 2 | HP:0003187 | |
| HumanPheno | Hypoplasia of penis | 2.19e-03 | 408 | 8 | 4 | HP:0008736 | |
| HumanPheno | Tetralogy of Fallot | 2.31e-03 | 185 | 8 | 3 | HP:0001636 | |
| HumanPheno | Skeletal dysplasia | 2.34e-03 | 186 | 8 | 3 | HP:0002652 | |
| HumanPheno | Generalized joint hypermobility | 2.35e-03 | 48 | 8 | 2 | HP:0002761 | |
| HumanPheno | Hypoparathyroidism | 2.55e-03 | 50 | 8 | 2 | HP:0000829 | |
| HumanPheno | Anosmia | 2.55e-03 | 50 | 8 | 2 | HP:0000458 | |
| HumanPheno | Obesity | 2.55e-03 | 425 | 8 | 4 | HP:0001513 | |
| HumanPheno | Sparse pubic hair | 2.65e-03 | 51 | 8 | 2 | HP:0002225 | |
| HumanPheno | Hyposmia | 2.75e-03 | 52 | 8 | 2 | HP:0004409 | |
| HumanPheno | Hypoplasia of the uterus | 2.75e-03 | 52 | 8 | 2 | HP:0000013 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 2.86e-03 | 53 | 8 | 2 | HP:0009906 | |
| HumanPheno | Abnormal hypothalamus physiology | 2.86e-03 | 53 | 8 | 2 | HP:0012285 | |
| HumanPheno | Decreased testicular size | 2.88e-03 | 200 | 8 | 3 | HP:0008734 | |
| HumanPheno | Abnormal larynx morphology | 2.93e-03 | 201 | 8 | 3 | HP:0025423 | |
| HumanPheno | Decreased serum estradiol | 2.97e-03 | 54 | 8 | 2 | HP:0008214 | |
| HumanPheno | Joint laxity | 3.07e-03 | 55 | 8 | 2 | HP:0001388 | |
| HumanPheno | Impotence | 3.07e-03 | 55 | 8 | 2 | HP:0000802 | |
| HumanPheno | Abnormality of the hypothalamus-pituitary axis | 3.13e-03 | 449 | 8 | 4 | HP:0000864 | |
| HumanPheno | Abnormality of the pubic hair | 3.30e-03 | 57 | 8 | 2 | HP:0100133 | |
| HumanPheno | Congenital hearing loss | 3.41e-03 | 58 | 8 | 2 | HP:0001729 | |
| HumanPheno | Congenital sensorineural hearing impairment | 3.41e-03 | 58 | 8 | 2 | HP:0008527 | |
| HumanPheno | Abnormal thymus morphology | 3.41e-03 | 58 | 8 | 2 | HP:0000777 | |
| MousePheno | abnormal diencephalon morphology | 7.28e-06 | 298 | 14 | 5 | MP:0000830 | |
| MousePheno | abnormal habenula morphology | 9.30e-06 | 5 | 14 | 2 | MP:0004082 | |
| MousePheno | abnormal clitoris size | 1.39e-05 | 6 | 14 | 2 | MP:0009100 | |
| MousePheno | abnormal clitoris morphology | 2.60e-05 | 8 | 14 | 2 | MP:0003127 | |
| MousePheno | abnormal posture | 7.77e-05 | 243 | 14 | 4 | MP:0001504 | |
| MousePheno | abnormal follicle stimulating hormone level | 8.63e-05 | 89 | 14 | 3 | MP:0003967 | |
| MousePheno | decreased vascular permeability | 1.41e-04 | 18 | 14 | 2 | MP:0003071 | |
| MousePheno | abnormal epithalamus morphology | 1.58e-04 | 19 | 14 | 2 | MP:0000840 | |
| MousePheno | abnormal circulating gonadotropin level | 1.71e-04 | 112 | 14 | 3 | MP:0003361 | |
| MousePheno | decreased uterus weight | 1.75e-04 | 20 | 14 | 2 | MP:0004905 | |
| MousePheno | abnormal external female genitalia morphology | 1.93e-04 | 21 | 14 | 2 | MP:0003126 | |
| MousePheno | delayed fertility | 1.93e-04 | 21 | 14 | 2 | MP:0002683 | |
| MousePheno | abnormal estrous cycle | 2.10e-04 | 120 | 14 | 3 | MP:0001927 | |
| MousePheno | abnormal ovulation cycle | 2.42e-04 | 126 | 14 | 3 | MP:0009344 | |
| MousePheno | abnormal hippocampus morphology | 2.56e-04 | 331 | 14 | 4 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 2.74e-04 | 337 | 14 | 4 | MP:0000801 | |
| MousePheno | abnormal pituitary gland morphology | 2.97e-04 | 135 | 14 | 3 | MP:0000633 | |
| MousePheno | prolonged diestrus | 3.99e-04 | 30 | 14 | 2 | MP:0009011 | |
| MousePheno | abnormal limbic system morphology | 4.25e-04 | 378 | 14 | 4 | MP:0004166 | |
| MousePheno | abnormal timing of vaginal opening | 4.26e-04 | 31 | 14 | 2 | MP:0020150 | |
| MousePheno | abnormal neuroendocrine gland morphology | 4.53e-04 | 156 | 14 | 3 | MP:0000631 | |
| MousePheno | abnormal uterus weight | 4.54e-04 | 32 | 14 | 2 | MP:0004903 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 5.13e-04 | 34 | 14 | 2 | MP:0002790 | |
| MousePheno | abnormal brain internal capsule morphology | 5.13e-04 | 34 | 14 | 2 | MP:0008128 | |
| MousePheno | abnormal diestrus | 5.44e-04 | 35 | 14 | 2 | MP:0009010 | |
| MousePheno | abnormal circulating pituitary hormone level | 6.03e-04 | 172 | 14 | 3 | MP:0005116 | |
| MousePheno | increased locomotor activity | 6.66e-04 | 178 | 14 | 3 | MP:0031391 | |
| MousePheno | abnormal learning/memory/conditioning | 7.70e-04 | 1239 | 14 | 6 | MP:0002063 | |
| MousePheno | abnormal cognition | 7.94e-04 | 1246 | 14 | 6 | MP:0014114 | |
| MousePheno | abnormal telencephalon morphology | 8.42e-04 | 812 | 14 | 5 | MP:0000787 | |
| MousePheno | decreased follicle stimulating hormone level | 8.60e-04 | 44 | 14 | 2 | MP:0005130 | |
| MousePheno | delayed sexual maturation | 1.07e-03 | 49 | 14 | 2 | MP:0001938 | |
| MousePheno | abnormal pituitary hormone level | 1.14e-03 | 214 | 14 | 3 | MP:0003965 | |
| MousePheno | abnormal neuronal precursor cell number | 1.20e-03 | 52 | 14 | 2 | MP:0004979 | |
| MousePheno | abnormal appendicular skeleton morphology | 1.32e-03 | 896 | 14 | 5 | MP:0009250 | |
| MousePheno | abnormal fear/anxiety-related behavior | 1.47e-03 | 919 | 14 | 5 | MP:0002065 | |
| MousePheno | decreased circulating gonadotropin level | 1.59e-03 | 60 | 14 | 2 | MP:0003363 | |
| MousePheno | decreased circulating hormone level | 1.74e-03 | 551 | 14 | 4 | MP:0014457 | |
| MousePheno | abnormal luteinizing hormone level | 1.81e-03 | 64 | 14 | 2 | MP:0003969 | |
| MousePheno | dilated lateral ventricle | 1.93e-03 | 66 | 14 | 2 | MP:0000825 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | 2.02e-03 | 1486 | 14 | 6 | MP:0002067 | |
| MousePheno | abnormal vascular permeability | 2.04e-03 | 68 | 14 | 2 | MP:0001619 | |
| MousePheno | abnormal nonmotile primary cilium morphology | 2.16e-03 | 70 | 14 | 2 | MP:0013205 | |
| MousePheno | abnormal startle reflex | 2.26e-03 | 591 | 14 | 4 | MP:0001486 | |
| MousePheno | abnormal neuron differentiation | 2.33e-03 | 275 | 14 | 3 | MP:0009937 | |
| MousePheno | abnormal cerebral hemisphere morphology | 2.37e-03 | 599 | 14 | 4 | MP:0008540 | |
| MousePheno | abnormal sexual maturation | 2.41e-03 | 74 | 14 | 2 | MP:0001937 | |
| MousePheno | reduced female fertility | 2.88e-03 | 296 | 14 | 3 | MP:0001923 | |
| MousePheno | abnormal forebrain morphology | 2.93e-03 | 1072 | 14 | 5 | MP:0000783 | |
| MousePheno | decreased hormone level | 2.93e-03 | 635 | 14 | 4 | MP:0014455 | |
| MousePheno | abnormal pectoral girdle bone morphology | 3.02e-03 | 301 | 14 | 3 | MP:0004508 | |
| Domain | 7tm_1 | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 5.09e-15 | 677 | 28 | 15 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 6.04e-15 | 685 | 28 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 6.87e-15 | 691 | 28 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 TACR3 MAS1L OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 7.02e-15 | 692 | 28 | 15 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR1G1 OR4D6 OR2B3 OR4D11 TACR1 TACR3 MAS1L OR52A4P OR10G2 OR51I1 OR4D10 CYSLTR1 OR4D9 FSHR | 1.29e-13 | 670 | 28 | 14 | IPR017452 |
| Domain | Olfact_rcpt | OR1G1 OR4D6 OR2B3 OR4D11 OR52A4P OR10G2 OR1D4 OR51I1 OR4D10 OR4D9 | 1.42e-10 | 393 | 28 | 10 | IPR000725 |
| Domain | Neurokn_rcpt | 6.50e-06 | 3 | 28 | 2 | IPR001681 | |
| Domain | BRK | 3.24e-05 | 6 | 28 | 2 | SM00592 | |
| Domain | BRK_domain | 3.24e-05 | 6 | 28 | 2 | IPR006576 | |
| Domain | BRK | 3.24e-05 | 6 | 28 | 2 | PF07533 | |
| Domain | Chromo_domain | 5.86e-04 | 24 | 28 | 2 | IPR023780 | |
| Domain | Chromo | 6.89e-04 | 26 | 28 | 2 | PF00385 | |
| Domain | CHROMO_2 | 8.00e-04 | 28 | 28 | 2 | PS50013 | |
| Domain | CHROMO_1 | 8.00e-04 | 28 | 28 | 2 | PS00598 | |
| Domain | SNF2_N | 1.05e-03 | 32 | 28 | 2 | PF00176 | |
| Domain | SNF2_N | 1.05e-03 | 32 | 28 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 1.05e-03 | 32 | 28 | 2 | IPR016197 | |
| Domain | CHROMO | 1.11e-03 | 33 | 28 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.11e-03 | 33 | 28 | 2 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.25e-03 | 35 | 28 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.47e-03 | 38 | 28 | 2 | PS00690 | |
| Domain | Helicase_C | 1.12e-02 | 107 | 28 | 2 | PF00271 | |
| Domain | HELICc | 1.12e-02 | 107 | 28 | 2 | SM00490 | |
| Domain | Helicase_C | 1.14e-02 | 108 | 28 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 1.16e-02 | 109 | 28 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.16e-02 | 109 | 28 | 2 | PS51192 | |
| Domain | DEXDc | 1.16e-02 | 109 | 28 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.18e-02 | 110 | 28 | 2 | IPR014001 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 7.67e-09 | 389 | 24 | 9 | M14091 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.40e-08 | 417 | 24 | 9 | M4072 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 5.20e-07 | 636 | 24 | 9 | M41834 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.78e-06 | 260 | 24 | 6 | M39397 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 2.77e-05 | 5 | 24 | 2 | MM14977 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 2.77e-05 | 5 | 24 | 2 | M27277 | |
| Pathway | WP_GPCRS_NONODORANT | 7.30e-05 | 266 | 24 | 5 | MM15843 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 8.06e-05 | 50 | 24 | 3 | M47951 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.20e-04 | 70 | 24 | 3 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 2.70e-04 | 75 | 24 | 3 | M39696 | |
| Pathway | WP_GPCRS_OTHER | 5.09e-04 | 93 | 24 | 3 | M39629 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.06e-03 | 272 | 24 | 4 | M13380 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.16e-03 | 330 | 24 | 4 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.24e-03 | 333 | 24 | 4 | MM14963 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.30e-03 | 178 | 24 | 3 | M2890 | |
| Pubmed | 2.65e-10 | 541 | 28 | 9 | 14983052 | ||
| Pubmed | The primary structure and gene organization of human substance P and neuromedin K receptors. | 6.25e-07 | 2 | 28 | 2 | 1312928 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24211491 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32067964 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 6.25e-07 | 2 | 28 | 2 | 20453063 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 8120392 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 8.26e-07 | 219 | 28 | 5 | 12213199 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 30277262 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 30108144 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18203813 | ||
| Pubmed | Expression of the tachykinin receptor mRNAs in healthy human colon. | 1.87e-06 | 3 | 28 | 2 | 18835556 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15130944 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28533432 | ||
| Pubmed | Molecular cloning of the murine substance K and substance P receptor genes. | 1.87e-06 | 3 | 28 | 2 | 1370937 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 8702757 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23285124 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16388914 | ||
| Pubmed | Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. | 6.24e-06 | 5 | 28 | 2 | 11786503 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 7.08e-06 | 340 | 28 | 5 | 11875048 | |
| Pubmed | 7.08e-06 | 340 | 28 | 5 | 11802173 | ||
| Pubmed | 7.39e-06 | 343 | 28 | 5 | 32295537 | ||
| Pubmed | 7.71e-06 | 346 | 28 | 5 | 14611657 | ||
| Pubmed | Characterization of the endokinins: human tachykinins with cardiovascular activity. | 9.36e-06 | 6 | 28 | 2 | 12716968 | |
| Pubmed | A role for tachykinins in the regulation of human sperm motility. | 9.36e-06 | 6 | 28 | 2 | 17437961 | |
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 9.36e-06 | 6 | 28 | 2 | 24705355 | |
| Pubmed | A role for tachykinins in female mouse and rat reproductive function. | 9.36e-06 | 6 | 28 | 2 | 12773411 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 17448763 | ||
| Pubmed | Neural basis of opioid-induced respiratory depression and its rescue. | 2.80e-05 | 10 | 28 | 2 | 34074761 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 8004088 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 6.16e-05 | 95 | 28 | 3 | 16754659 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 7.45e-05 | 16 | 28 | 2 | 10673334 | |
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 15452121 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.72e-04 | 351 | 28 | 4 | 38297188 | |
| Pubmed | 2.33e-04 | 28 | 28 | 2 | 20301509 | ||
| Pubmed | 3.35e-04 | 418 | 28 | 4 | 34709266 | ||
| Pubmed | Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans. | 4.78e-04 | 40 | 28 | 2 | 33238113 | |
| Pubmed | 5.53e-04 | 43 | 28 | 2 | 23597562 | ||
| Pubmed | 7.77e-04 | 225 | 28 | 3 | 12168954 | ||
| Interaction | TAC4 interactions | 7.47e-06 | 4 | 23 | 2 | int:TAC4 | |
| Cytoband | 11q12.1 | 2.79e-06 | 161 | 28 | 4 | 11q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 5.56e-05 | 345 | 28 | 4 | chr11q12 | |
| Cytoband | 17p13.3 | 1.33e-03 | 88 | 28 | 2 | 17p13.3 | |
| Cytoband | 14q11.2 | 5.40e-03 | 180 | 28 | 2 | 14q11.2 | |
| Cytoband | 11p15.4 | 6.63e-03 | 200 | 28 | 2 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 1.74e-02 | 332 | 28 | 2 | chr14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.88e-02 | 346 | 28 | 2 | chr17p13 | |
| GeneFamily | Tachykinin receptors | 4.64e-06 | 3 | 23 | 2 | 258 | |
| GeneFamily | Olfactory receptors, family 4 | 1.97e-05 | 129 | 23 | 4 | 151 | |
| GeneFamily | Olfactory receptors, family 1 | 1.17e-03 | 40 | 23 | 2 | 147 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | 3.10e-05 | 200 | 24 | 4 | M9083 | |
| Drug | senktide | 1.46e-06 | 2 | 28 | 2 | ctd:C054724 | |
| Drug | talnetant | 3.76e-06 | 25 | 28 | 3 | CID000133090 | |
| Drug | (N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide) | 4.37e-06 | 3 | 28 | 2 | ctd:C502587 | |
| Drug | 4-quinolinecarboxamide | 8.74e-06 | 4 | 28 | 2 | CID003753329 | |
| Drug | Men10354 | 8.74e-06 | 4 | 28 | 2 | CID003083370 | |
| Drug | AC1MQSA5 | 8.87e-06 | 33 | 28 | 3 | CID003481669 | |
| Drug | 2-(4-nitrophenyl)benzoxazole | 1.46e-05 | 5 | 28 | 2 | CID000070047 | |
| Drug | AC1L51LV | 1.46e-05 | 5 | 28 | 2 | CID000196380 | |
| Drug | Urechistachykinin I | 2.18e-05 | 6 | 28 | 2 | CID000192432 | |
| Drug | 4-phenylpiperidine-4-carboxamide | 2.18e-05 | 6 | 28 | 2 | CID003017129 | |
| Drug | Ranatachykinin A | 2.18e-05 | 6 | 28 | 2 | CID000195814 | |
| Drug | Spm-SP | 2.18e-05 | 6 | 28 | 2 | CID003081857 | |
| Drug | L-659,837 | 3.05e-05 | 7 | 28 | 2 | CID006444163 | |
| Drug | Men 10456 | 3.05e-05 | 7 | 28 | 2 | CID000189859 | |
| Drug | L015496 | 3.05e-05 | 7 | 28 | 2 | CID004529080 | |
| Drug | GR159897 | 3.05e-05 | 7 | 28 | 2 | CID003570748 | |
| Drug | AC1O44I5 | 3.05e-05 | 7 | 28 | 2 | CID006324620 | |
| Drug | Neurokinin A-oh | 3.05e-05 | 7 | 28 | 2 | CID000147040 | |
| Drug | DAU 6285 | 3.05e-05 | 7 | 28 | 2 | CID000129927 | |
| Drug | SB 235375 | 3.05e-05 | 7 | 28 | 2 | CID009846078 | |
| Drug | S 5192 | 3.05e-05 | 7 | 28 | 2 | CID003946663 | |
| Drug | LY303870 | 3.05e-05 | 7 | 28 | 2 | CID003086681 | |
| Drug | Lom-TK-I | 4.07e-05 | 8 | 28 | 2 | CID000195503 | |
| Drug | AC1L4Z4R | 4.07e-05 | 8 | 28 | 2 | CID000194918 | |
| Drug | Bhsar-SP | 4.07e-05 | 8 | 28 | 2 | CID000163829 | |
| Drug | AC1Q5IQA | 4.07e-05 | 8 | 28 | 2 | CID000163732 | |
| Drug | Amino-senktide | 4.07e-05 | 8 | 28 | 2 | CID000128590 | |
| Drug | phyllomedusin | 5.22e-05 | 9 | 28 | 2 | CID000168489 | |
| Drug | AC1MIXOF | 5.22e-05 | 9 | 28 | 2 | CID003081850 | |
| Drug | inaperisone | 5.22e-05 | 9 | 28 | 2 | CID000065860 | |
| Drug | SP(3-11) | 5.22e-05 | 9 | 28 | 2 | CID003084968 | |
| Drug | Sp(7-11) | 5.22e-05 | 9 | 28 | 2 | CID003084967 | |
| Drug | Uperolein | 6.52e-05 | 10 | 28 | 2 | CID003085088 | |
| Drug | R 487 | 6.52e-05 | 10 | 28 | 2 | CID000131469 | |
| Drug | R396 | 6.52e-05 | 10 | 28 | 2 | CID000164286 | |
| Drug | AC1L2Y4S | 6.52e-05 | 10 | 28 | 2 | CID000130848 | |
| Drug | Nka-(4-10) | 7.97e-05 | 11 | 28 | 2 | CID000122230 | |
| Drug | ezlopitant | 7.97e-05 | 11 | 28 | 2 | CID000188927 | |
| Drug | Mdl 28,564 | 7.97e-05 | 11 | 28 | 2 | CID003081745 | |
| Drug | Cp96 | 7.97e-05 | 11 | 28 | 2 | CID000086380 | |
| Drug | AC1Q5XN5 | 7.97e-05 | 11 | 28 | 2 | CID000190946 | |
| Drug | norbiotin | 9.39e-05 | 72 | 28 | 3 | CID000446903 | |
| Drug | [Sar9]-Substance-?P | 9.55e-05 | 12 | 28 | 2 | CID005049868 | |
| Drug | Mdl 29913 | 9.55e-05 | 12 | 28 | 2 | CID003081272 | |
| Drug | Scyliorhinin I | 1.13e-04 | 13 | 28 | 2 | CID000147048 | |
| Drug | PD140548 | 1.13e-04 | 13 | 28 | 2 | CID005311347 | |
| Drug | chloropyramine | 1.32e-04 | 14 | 28 | 2 | CID000025294 | |
| Drug | Gr 73632 | 1.32e-04 | 14 | 28 | 2 | CID000119599 | |
| Drug | Gr-94800 | 1.73e-04 | 16 | 28 | 2 | CID005487475 | |
| Drug | Fk 224 | 1.73e-04 | 16 | 28 | 2 | CID006437864 | |
| Drug | Azlaire | 1.73e-04 | 16 | 28 | 2 | CID000115100 | |
| Drug | Men 10627 | 1.73e-04 | 16 | 28 | 2 | CID006438356 | |
| Drug | substance P methyl ester | 1.96e-04 | 17 | 28 | 2 | CID004588685 | |
| Drug | L-732,138 | 1.96e-04 | 17 | 28 | 2 | CID000132837 | |
| Drug | L-703, 606 oxalate | 1.96e-04 | 17 | 28 | 2 | CID000003851 | |
| Drug | alaninamide | 1.96e-04 | 17 | 28 | 2 | CID000350287 | |
| Drug | MEN 11420 | 1.96e-04 | 17 | 28 | 2 | CID003086682 | |
| Drug | Hydrochloric Acid | 2.07e-04 | 94 | 28 | 3 | ctd:D006851 | |
| Drug | Dimethyl C7 | 2.20e-04 | 18 | 28 | 2 | CID000123994 | |
| Drug | GR 64349 | 2.46e-04 | 19 | 28 | 2 | CID003036081 | |
| Drug | dibenzyl | 2.73e-04 | 20 | 28 | 2 | CID000007647 | |
| Drug | Sendide | 2.73e-04 | 20 | 28 | 2 | CID000122140 | |
| Drug | AC1L1KWW | 2.73e-04 | 20 | 28 | 2 | CID000005688 | |
| Drug | ARC 239 | 3.02e-04 | 21 | 28 | 2 | CID000609483 | |
| Drug | neurokinin-1 receptor antagonist | 3.02e-04 | 21 | 28 | 2 | CID001122655 | |
| Drug | N-acetyl-L-tryptophan | 3.32e-04 | 22 | 28 | 2 | CID000002002 | |
| Drug | Sp(1-7) | 3.32e-04 | 22 | 28 | 2 | CID000115322 | |
| Drug | Substance P Octapeptide | 3.63e-04 | 23 | 28 | 2 | CID000171298 | |
| Drug | aganodine | 3.63e-04 | 23 | 28 | 2 | CID000176878 | |
| Drug | AC1Q6SH8 | 3.85e-04 | 116 | 28 | 3 | CID000000009 | |
| Drug | myo-inositol | 3.86e-04 | 811 | 28 | 6 | CID000000892 | |
| Drug | estradiol-17 beta-benzoate | 3.96e-04 | 24 | 28 | 2 | ctd:C010452 | |
| Drug | SR 142801 | 3.96e-04 | 24 | 28 | 2 | CID000219077 | |
| Drug | Salnacedin | 4.30e-04 | 25 | 28 | 2 | CID003058743 | |
| Drug | Bhg-(2-1)fuc | 4.30e-04 | 25 | 28 | 2 | CID005287784 | |
| Drug | Men 10376 | 4.65e-04 | 26 | 28 | 2 | CID000124003 | |
| Drug | L-733,060 | 4.65e-04 | 26 | 28 | 2 | CID000132846 | |
| Drug | RP 67580 | 4.65e-04 | 26 | 28 | 2 | CID000107686 | |
| Drug | Septide | 4.65e-04 | 26 | 28 | 2 | CID000119137 | |
| Drug | C15873 | 5.02e-04 | 27 | 28 | 2 | CID000045749 | |
| Drug | L 659877 | 5.02e-04 | 27 | 28 | 2 | CID000164213 | |
| Drug | NPS R-568 | 5.02e-04 | 27 | 28 | 2 | CID000158796 | |
| Drug | Sch 39370 | 5.02e-04 | 27 | 28 | 2 | CID000121872 | |
| Drug | Senktide | 5.40e-04 | 28 | 28 | 2 | CID000108147 | |
| Drug | 5(G)-TASP | 5.80e-04 | 29 | 28 | 2 | CID000488931 | |
| Drug | quinuclidine | 6.63e-04 | 31 | 28 | 2 | CID000007527 | |
| Drug | Eledoisinum | 7.99e-04 | 34 | 28 | 2 | CID000006242 | |
| Drug | ICI 198,615 | 7.99e-04 | 34 | 28 | 2 | CID000115219 | |
| Drug | Physalemin | 8.46e-04 | 35 | 28 | 2 | CID000017268 | |
| Drug | mepyramine | 8.78e-04 | 154 | 28 | 3 | CID000004992 | |
| Drug | L-365,260 | 9.46e-04 | 37 | 28 | 2 | CID000104929 | |
| Drug | CID5147932 | 9.98e-04 | 38 | 28 | 2 | CID005147932 | |
| Drug | Bolton-Hunter reagent | 9.98e-04 | 38 | 28 | 2 | CID000123813 | |
| Drug | AC1L3XLM | 1.05e-03 | 39 | 28 | 2 | CID000123946 | |
| Drug | emend | 1.11e-03 | 40 | 28 | 2 | CID000151165 | |
| Drug | 2-methyl-5-HT | 1.11e-03 | 40 | 28 | 2 | CID000001574 | |
| Drug | CP-99,994 | 1.16e-03 | 41 | 28 | 2 | CID000105083 | |
| Drug | Zymosan | 1.21e-03 | 172 | 28 | 3 | ctd:D015054 | |
| Drug | Fk 888 | 1.22e-03 | 42 | 28 | 2 | CID000107967 | |
| Drug | endomorphin 2 | 1.22e-03 | 42 | 28 | 2 | CID005311081 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.33e-05 | 7 | 24 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 9.62e-05 | 18 | 24 | 2 | C0342384 | |
| Disease | Kallmann Syndrome | 2.04e-04 | 26 | 24 | 2 | C0162809 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 3.10e-04 | 32 | 24 | 2 | EFO_0010363 | |
| Disease | Alcohol Use Disorder | 5.87e-04 | 44 | 24 | 2 | C0001956 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 8.84e-04 | 54 | 24 | 2 | DOID:6432 (implicated_via_orthology) | |
| Disease | Alcohol abuse | 1.36e-03 | 67 | 24 | 2 | C0085762 | |
| Disease | diabetes mellitus | 1.40e-03 | 68 | 24 | 2 | EFO_0000400 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.44e-03 | 69 | 24 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | 1.48e-03 | 1069 | 24 | 5 | EFO_0004346 | |
| Disease | daytime rest measurement | 1.71e-03 | 295 | 24 | 3 | EFO_0007828 | |
| Disease | cortical thickness | 1.77e-03 | 1113 | 24 | 5 | EFO_0004840 | |
| Disease | basophil percentage of granulocytes | 2.07e-03 | 83 | 24 | 2 | EFO_0007995 | |
| Disease | free androgen index | 3.36e-03 | 374 | 24 | 3 | EFO_0007005 | |
| Disease | balding measurement | 3.57e-03 | 792 | 24 | 4 | EFO_0007825 | |
| Disease | cortical thickness, neuroimaging measurement | 3.60e-03 | 110 | 24 | 2 | EFO_0004346, EFO_0004840 | |
| Disease | cortical surface area measurement | 4.02e-03 | 1345 | 24 | 5 | EFO_0010736 | |
| Disease | asthma (is_marker_for) | 4.70e-03 | 126 | 24 | 2 | DOID:2841 (is_marker_for) | |
| Disease | chronotype measurement | 5.23e-03 | 882 | 24 | 4 | EFO_0008328 | |
| Disease | photoreceptor cell layer thickness measurement | 6.42e-03 | 148 | 24 | 2 | EFO_0803370 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.75e-03 | 152 | 24 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | basophil count | 6.83e-03 | 483 | 24 | 3 | EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TICRAILVYCLLHYR | 1481 | Q9HCK8 | |
| LLIYIPAVVLYCCCL | 121 | Q9Y672 | |
| TICRTILVYCLNHYK | 1641 | Q9P2D1 | |
| PRCIYCIHALSLYLF | 146 | P46940 | |
| VVTLHFVPCIYVYAR | 246 | Q8NGI4 | |
| DRYVAVCRPLHYVVI | 121 | O76000 | |
| VAICYPLRYVTVLTH | 126 | Q9H343 | |
| ILYPIICTYHLVQSL | 271 | A6NMU1 | |
| YRHFLQITLCVCELY | 126 | Q9BY08 | |
| VVTLHFVPCVYIYCR | 246 | Q8NGJ1 | |
| RAPLLDYIYRVLHCC | 1291 | Q2PPJ7 | |
| YILHLVAADVIYLCC | 111 | P35410 | |
| DCYVAICHPLHYILI | 121 | P47890 | |
| IDIAVYCRHYCLLPL | 536 | Q9ULD6 | |
| VVTLHFVPCIYVYAR | 246 | Q8NGE8 | |
| LYIVPELCILYRSCR | 256 | Q9NZD1 | |
| AFVVICGCYIHIYLT | 541 | P23945 | |
| CGSHLIVVTVYYVPC | 246 | Q8NGC3 | |
| DRYVAICCPLHYVTA | 121 | P47884 | |
| VVTLHFVPCIYVYAR | 246 | Q8NGI6 | |
| YTCPICLEVYHRPVA | 31 | Q96A37 | |
| YHICVTVLIYFLPLL | 196 | P25103 | |
| CLRLLRVYTCEIYPV | 1466 | O75592 | |
| TYHIIVIILVYCFPL | 246 | P29371 | |
| LCVCTLPLRVVYYVH | 71 | Q9Y271 | |
| YHLCIVNLVIGTLYC | 541 | Q8N4P2 | |
| ERPYICKICHYPFTV | 696 | Q92766 | |
| AHICQYCLEVLPSLY | 436 | Q96K83 | |
| LFHYICQDRIVYLCI | 51 | P51809 | |
| YHLCIVNLVIGTLYC | 541 | Q86WT1 |